Healthcare Investing

Investing in better outcomes

Healthcare is entering a golden age of innovation, with genetic sequencing and other advanced technologies enabling a rapid pace of medical breakthroughs

At the same time, demand for care is growing as populations age and unmet medical needs persist. These dynamics are creating sizable growth opportunities - with potentially positive outcomes for patients and investors alike. Janus Henderson's healthcare strategy draws on deep scientific expertise to invest across pharmaceuticals, biotechnology, medical devices, and healthcare services, seeking long-term risk-adjusted returns in one of the most dynamic sectors in global equity markets.

Investment opportunities in healthcare for investors


crowd of people in street

Demographics

Between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12% to 22%*. This, coupled with globalisation and population growth around the world, is a natural, persistent tailwind for the healthcare sector.

* World Health Organization, Ageing and health, 1 October 2025.

Technology and AI

Innovation is crucial for investing in healthcare. Companies with groundbreaking medical products that improve patient care or meet unmet needs have achieved returns, even as the broader market has struggled. Examples include improved med tech devices and robotics for surgical procedures.

surgon using technology during surgery
person pointing at graph

Mergers and acquisitions (M&A)

M&A is an important feature of the healthcare landscape, offering a pathway for innovative biotech companies to see long-term potential recognised earlier, underpinned by strong balance sheets and continued pipeline demand across large-cap pharma.

Our healthcare funds are designed to:


Identify healthcare's best scientific and commercial opportunities

Focus on small- and mid-cap biotech companies, aiming to maximise the sector's growth potential

Mitigate downside risk through a proprietary value-at-risk framework

View our healthcare funds


Horizon Biotechnology Fund


How to integrate healthcare in my investment portfolio?


"Investors who have added health care to their global equity portfolio would have experienced superior risk-adjusted returns."

Sabrina Denis
Senior Associate Director, Investment Specialist

Why invest in healthcare with Janus Henderson?


hand with healthcare symbol

Over 125 years' experience

Janus Henderson's healthcare investment team includes 3 PhDs and 1 MD, with over 125 years of combined experience in healthcare investing.

balanced scale

20+ year healthcare strategy now available as an OEIC

Healthcare has historically shown the widest performance gap between top- and bottom-performing stocks of any equity sector. Our long-term, risk/reward-focused approach is designed to navigate this dispersion.

magnifying glass

A long-term approach

Deep fundamental research, a disciplined long-term framework, and a specialist investment team set Janus Henderson apart in pursuing superior risk-adjusted returns in healthcare.

Insights


A mid-year checkup on the healthcare sector

Healthcare’s mix of innovation and defensive characteristics is helping support a compelling opportunity set for investors.

The AI tide rolls on

Investors questioning the scale of AI CapEx or the theme’s durability need only look to extensive supply bottlenecks to assuage concerns.

Beyond weight loss: What’s next for GLP-1s in 2026 and beyond

New drug formats and emerging indications are expanding the potential reach of GLP-1 therapies and shaping the market’s next phase of growth.

Meet our healthcare investment team


Andy Acker, CFA
Portfolio Manager,
Global Life Sciences Strategy
In the field of healthcare investing since 2007
Daniel Lyons, PhD, CFA
Portfolio Manager, Global Life Sciences Strategy
In the field of healthcare investing since 2000
Agustin Mohedas, PhD
Portfolio Manager, Biotechnology Strategy
In the field of healthcare investing since 2014
View broader team

Vish Sridharan, MD
Biotechnology

Luyi Guo, PhD, CFA
Pharmaceuticals

Tim McCarty, CFA
Medical Technology

Adam Poussard, CFA
Medical Technology

Lauren Petite
Medical Technology

Important information

Please read the following important information regarding these funds.

Access transformational change with thematic investing.

Thematic investing enables investors to benefit from the powerful megatrends that are disrupting and shaping the future, unlocking the potential for stronger and more consistent returns.